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Abstract
Background:  Regardless  the  progress  in  perioperative  care  postoperative  cognitive  decline
(PCD) has  been  accepted  unequivocally  as  a  signiﬁcant  and  frequent  complication  of  surgery  in
older patients.  The  aim  of  this  study  was  to  evaluate  the  incidence  of  postoperative  cognitive
decline and  its  inﬂuence  on  quality  of  life  three  months  after  surgery.
Methods:  Observational,  prospective  study  in  a  Post-Anesthesia  Care  Unit  (PACU)  in  patients
aged above  45  years,  after  elective  major  surgery.  Cognitive  function  was  assessed  with  Montreal
Cognitive  Assessment  (MOCA);  Quality  of  life  (QoL)  was  assessed  using  SF-36  Health  Survey
(SF-36). Assessments  were  performed  preoperatively  (T0)  and  3  months  after  surgery  (T3).
Results:  Forty-one  patients  were  studied.  The  incidence  of  PCD  3  months  after  surgery  was
24%. At  T3  MOCA  scores  were  lower  in  patients  with  PCD  (median  20  vs.  25,  p  =  0.009).  When
comparing  the  median  scores  for  each  of  SF-36  domains,  there  were  no  differences  between
patients with  and  without  PCD.  In  patients  with  PCD,  and  comparing  each  of  SF-36  domains
obtained before  and  three  months  after  surgery,  had  similar  scores  for  every  of  the  8  SF-36
areas while  patients  without  PCD  had  better  scores  for  six  domains.  At  T3  patients  with  PCD
presented  with  higher  levels  of  dependency  in  personal  activities  of  daily  living  (ADL).
Conclusion:  Three  months  after  surgery  patients  without  PCD  had  signiﬁcant  improvement  in
MOCA scores.  Patients  with  PCD  obtained  no  increase  in  SF-36  scores  but  patients  without  PCD
improved in  almost  all  SF-36  domains.  Patients  with  PCD  presented  higher  rates  of  dependency
in personal  ADL  after  surgery.
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Impacto  do  declínio  cognitivo  após  cirurgia  sobre  a  qualidade  de  vida:  estudo
prospectivo
Resumo
Justiﬁcativa  e  objetivo:  Independente  do  progresso  do  tratamento  no  período  perioperatório,
o declínio  cognitivo  no  pós-operatório  (DCPO)  é  inequivocamente  aceito  como  uma  complicac¸ão
importante  e  frequente  da  cirurgia  em  pacientes  mais  velhos.  O  objetivo  deste  estudo  foi  avaliar
a incidência  de  DCPO  e  sua  inﬂuência  na  qualidade  de  vida  três  meses  após  a  cirurgia.
Métodos: Estudo  prospectivo  observacional  conduzido  em  Sala  de  Recuperac¸ão  Pós-anestesia
(SRPA) com  pacientes  de  idade  superior  a  45  anos,  após  cirurgia  eletiva  de  grande  porte.  A  func¸ão
cognitiva foi  avaliada  com  o  teste  de  Avaliac¸ão  Cognitiva  de  Montreal  (MOCA)  e  a  qualidade  de
vida (QV)  com  o  Questionário  sobre  Qualidade  de  Vida  (SF-36).  As  avaliac¸ões  foram  realizadas
no pré-operatório  (T0)  e  três  meses  após  a  cirurgia  (T3).
Resultados:  Quarenta  e  um  pacientes  foram  avaliados.  A  incidência  de  DCPO  três  meses  após  a
cirurgia foi  de  24%.  Em  T3,  os  escores  MOCA  foram  menores  nos  pacientes  com  DCPO  (mediana
20 vs.  25,  p  =  0,009).  Ao  comparar  as  medianas  dos  escores  para  cada  um  dos  domínios  do  SF-
36, não  observamos  diferenc¸as  entre  os  pacientes  com  e  sem  DCPO.  Ao  comparar  cada  um  dos
domínios do  SF-36  obtidos  antes  e  após  três  meses  de  cirurgia,  os  pacientes  com  DCPO  apre-
sentaram  resultados  semelhantes  para  cada  uma  das  oito  áreas  do  SF-36,  enquanto  pacientes
sem DCPO  apresentaram  resultados  melhores  em  seis  domínios.  Em  T3,  os  pacientes  com  DCPO
apresentaram  níveis  mais  elevados  de  dependência  na  realizac¸ão  de  atividades  cotidianas.
Conclusão:  Três  meses  após  a  cirurgia,  os  pacientes  sem  DCPO  apresentaram  melhora  signi-
ﬁcativa dos  escores  MOCA.  Os  pacientes  com  DCPO  não  apresentaram  aumento  dos  escores
SF-36, mas  os  pacientes  sem  DCPO  apresentaram  melhora  em  quase  todos  os  domínios  do  SF-
36. Os  pacientes  com  DCPO  apresentaram  taxas  mais  elevadas  de  dependência  na  realizac¸ão
de atividades  cotidianas  após  a  cirurgia.
© 2016  Publicado  por  Elsevier  Editora  Ltda.  em  nome  de  Sociedade  Brasileira  de  Anestesiologia.
Este e´ um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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egardless  the  progress  in  perioperative  care,  postoperative
ognitive  decline  (PCD)  has  been  accepted  unequivocally  as
 signiﬁcant  and  frequent  complication  of  surgery  in  older
atients.1--12 However,  there  is  still  no  consensus  deﬁnition
f  PCD  in  the  medical  community,  and  broadly,  it  refers  to
 temporary  decline  in  cognition  associated  with  surgery.13
f  it  last  longer  than  three  months  is  deﬁned  as  long-term
ostoperative  cognitive  decline,13,14 and  a  considerable  pro-
ortion  of  patients  do  not  recover  three  months  after  surgery
73--69%  in  cardiac  surgery).15
The  exact  etiology  of  PCD  remains  unclear  and  is  prob-
bly  multifactorial.15,16 Complications  in  the  perioperative
eriod  may  anticipate  early  PCD,  but  increasing  age  has  been
hown  to  be  a  signiﬁcant  and  independent  risk  factor  for
CD.  The  incidence  of  PCD  is  expected  to  increase  as  the
opulation  of  older  surgical  patients  grows.11,17
Patients  submitted  to  cardiac  surgery  have  been  pro-
usely  studied,  however,  the  incidence  and  prevalence  of
his  complication  after  other  types  of  surgery  has  not  been
o  exhaustively  reported.16,18 The  International  Study  of
ostoperative  Cognitive  Dysfunction  (ISPOCD)  group  stud-
ed  1218  patients  aged  60  years  old  or  older,  undergoing
ajor  general  surgery  and  reported  an  incidence  of  PCD  ofPlease  cite  this  article  in  press  as:  Borges  J,  et  al.  Impact  of  post
study.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.
5.8--9.9%,  one  week  and  three  months  following  surgery,
espectively.6 However,  the  estimation  of  the  frequency  of
CD  still  varies  from  25%  to  80%.4
m
l
hThe  diagnosis  of  PCD  requires  valid  and  accurate  pre-
perative  and  postoperative  neuropsychological  testing  and
he  determination  of  a  cut-off  point  between  PCD  and  nor-
al  variation  in  cognitive  performance.  PCD  diagnosis  is  not
asy  to  perform  and  it  has  no  apparent  clinical  symptoms  --
atients  may  present  an  impairment  in  one  or  various  cog-
itive  abilities  such  as  memory,  attention,  concentration,
peed  of  motor  and  mental  response,  information  processing
nd  learn  after  surgery  and  anesthesia  that  is  different
rom  delirium.4,13,19 It  has  a  subtle  manner  of  manifestation,
ommonly  many  days  or  weeks  after  surgery.2,4 Numerous
linicians  fail  to  recognize  the  subject’s  cognitive  decline
ollowing  surgery;  but  also  the  patients  themselves,  due  to
nattention  or  embarrassment,  may  not  be  aware  of  their
CD  or  be  reluctant  to  report  any  alteration.4 Until  now,
here  is  no  standard  accepted  approach  for  its  diagnosis,
nd  it  is  essential  use  several  valid  and  highly  sensitive  neu-
opsychological  tests,  which  allow  assessing  many  cognitive
reas.4,19--21
Although  cognitive  changes  are  not  manifested  clinically
n  some  patients,  recent  studies  show  that  PCD  may  lead  to
 prolonged  hospital  stay,  elevated  medical  costs,  increased
orbidity  and  readmission  to  hospital.  PCD  has  long-term
onsequences  in  terms  of  increased  all-cause  mortality  and
eclined  in  Quality  of  Life  (QoL),  associated  with  impair-operative  cognitive  decline  in  quality  of  life:  a  prospective
bjane.2016.07.012
ents  in  daily  functioning,  premature  departure  from  the
abor  market,  and  dependency  on  economic  assistance  after
ospital  discharge.2,8,9
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Postoperative  cognitive  decline  
The  purpose  of  this  study  was  to  assess  the  incidence  of
PCD  and  cognitive  recovery  3  months  following  non-cardiac
and  non-neurological  surgery  and  to  determine  the  impact
of  cognitive  decline  in  QoL  and  dependency  in  activities  of
the  daily  living.
Methods
Ethics
Ethical  approval  for  this  study  (Ethical  Committee  approval
n◦ 127/12)  was  provided  by  Comité  de  Ética  para  a  Saúde  do
Centro  Hospitalar  de  São  João,  Porto,  Portugal  (Chairperson:
Professor  Filipe  Almeida)  on  May  25,  2012.  Written  consent
was  obtained  from  all  patients.
The  cohort
A  total  of  221  patients  undergoing  elective  major  surgery
were  enrolled  in  the  study,  conducted  from  18th  June  to
15th  July  2012,  in  the  multidisciplinary  Post-Anesthesia
Care  Unit  (PACU).  The  inclusion  criteria  involved  adult
Portuguese-speaking  patients  submitted  to  major  elective
surgery  (deﬁned  as  surgery  that  requires  two  or  more  days
of  hospital  stay)  requiring  anesthesia,  aged  45  years  old
and  older.  Patients  could  not  be  included  twice,  even  if
they  had  an  unrelated  second  procedure.  Patients  were  also
excluded  if  they  (1)  had  cognitive  impairment  at  baseline
assessment  considered  for  patients  with  a  Mini-Mental  State
Examination  (MMSE)  score22 of  less  than  24;  (2)  had  not  pro-
vided  or  were  incapable  of  providing  informed  consent;  (3)
were  unable  to  understand  the  language  used  or  were  illit-
erate;  (4)  were  unwilling  to  comply  with  the  protocol  or
procedures;  (5)  had  been  submitted  to  urgent  or  emergent
surgery;  (6)  had  been  admitted  for  obstetric,  neurological
or  cardiac  surgery;  and  (7)  were  admitted  to  intensive  care
units  for  postoperative  vigilance.  All  patients  were  inter-
viewed  either  on  the  eve  or  the  day  of  the  surgery  (at
least  3  h  before).  It  was  then  conducted  a  small  consulta-
tion  to  obtain  consent,  to  perform  MMSE  test  and  to  collect
the  medical  history.  Patients  completed  neuropsychologi-
cal  tests  at  entry  to  the  study  (T0)  and  three  months  after
surgery  (T3).  These  tests  included  the  Montreal  Cognitive
Assessment  test  (MOCA),23 the  Medical  Outcomes  Study  36
items  Short  Form  Health  Survey  test  (SF-36),24 the  Law-
ton  instrumental  activities  of  the  daily  living  scale  (Lawton
scale)25 and  the  Katz  Index  of  Independence  in  activities
of  the  daily  living  (Katz’s  Index).26 Anesthesiologists  were
blinded  to  patient  involvement  in  the  study.  Conduct  of
anesthesia,  including  the  choice  of  the  type  of  anesthesia
was  at  the  discretion  of  the  anesthesiologist.
Patient  assessment
The  recorded  patients’  characteristics  were:  age,  weight,
height,  body  mass  index  (BMI)  and  American  Society  of
Anaesthesiologists  Physical  Status  (ASA-PS).  The  RevisedPlease  cite  this  article  in  press  as:  Borges  J,  et  al.  Impact  of  post
study.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.
Cardiac  Risk  Index  (RCRI)  was  also  calculated,  using  the  clas-
siﬁcation  system  reported  by  Lee  et  al.,27 which  includes
high-risk  surgery  (i.e.,  intraperitoneal,  intrathoracic,  or
suprainguinal  vascular  procedures)  and  clinical  risk  factors:
p
i
a
n PRESS
3
istory  of  ischemic  heart  disease,  compensated  or  prior
eart  failure,  cerebrovascular  disease,  diabetes  mellitus
nd  renal  insufﬁciency.  These  variables  are  included  in  the
ardiac  Risk  Stratiﬁcation  for  Non-cardiac  Surgical  Proce-
ures  of  the  2007  guidelines  on  Perioperative  Cardiovascular
valuation  and  Care  for  Non-cardiac  Surgery  of  the  Ameri-
an  College  of  Cardiology/American  Heart  Association  Task
orce  on  Practice  Guidelines.28
Intraoperative  details,  including  type  and  duration  of
nesthesia  and  surgical  procedures,  length  of  PACU  stay  and
ny  cardiorespiratory  events  in  this  unit  were  also  docu-
ented.
valuation  of  PCD  and  quality  of  life
ach  participant  underwent  neuropsychological  testing  at
wo-time  points:  preoperatively  (T0)  and  three  months  after
urgery  (T3).
All patients  completed  baseline  assessments  of  general
ognitive  functioning  assessed  by  the  Mini-Mental  State
xamination.  MMSE  is  a  valid  and  recognized  test,  performed
n  5--10  min;  that  evaluates  cognitive  status.  It  grossly  evalu-
tes  executive  cognitive  function  by  measuring  orientation,
alculations,  memory,  reading  and  writing  capacities,  lan-
uage  and  visuospatial  ability.  Even  so,  patients  with  mild
orms  of  cognitive  decline  frequently  score  in  the  normal
ange  in  the  MMSE.22
Montreal  cognitive  assessment  test  is  a  one-page  ques-
ionnaire  that  takes  10  min  to  perform  and  is  suitable  to
valuate  short-term  memory,  executive  functions,  working
emory,  concentration,  visuospatial  abilities,  attention,
anguage,  and  temporal  and  spatial  orientation.  The  score
ange  varies  from  0  to  30,  and  higher  scores  indicate  better
ognitive  performance.  To  adjust  for  educational  effects,
ubjects  with  12  or  fewer  years  of  education  receive
n  extra  point.23,29,30 Several  studies  were  conducted  in
ortugal  concerning  the  Portuguese  experimental  version
f  the  MOCA,  and  the  studies’  conclusions  appear  to  assure
he  validity  and  clinical  utility  of  this  tool.30 Adopting  the
riterion  used  by  Baracchini  et  al.1 a  decline  of  at  least
 points  in  MOCA  test  at  T3  was  considered  as  clinically
elevant  and  deﬁned  as  PCD.
The  Medical  Outcomes  Study  36  Item  Short  Form  Health
urvey24 aims  to  quantify  general  health  condition  and  con-
ists  of  eight  sections  or  domains,  which  are  the  weighted
ums  of  the  questions  in  their  section.  The  eight  domains
re  vitality,  physical  functioning,  bodily  pain,  general  health
erceptions,  physical  role  functioning,  emotional  role  func-
ioning,  social  role  functioning,  and  mental  health.  This
uestionnaire  has  also  been  culturally  adapted  to  the  Por-
uguese  and  validated  in  a  study  by  Ferreira  et  al.31,32
Evaluation  of  functional  capacity  was  based  on  the  ability
f  the  patient  to  undertake  personal  and  instrumental  activ-
ties  of  daily  living.  To  do  so,  two  questionnaires  that  assess
he  functional  independence  of  the  subject  to  accomplish
nstrumental  ADL  (I-ADL)  and  personal  ADL  (P-ADL)  were
sed:  the  Lawton  I-ADL  scale25 and  the  Katz’s  Index  of  Inde-operative  cognitive  decline  in  quality  of  life:  a  prospective
bjane.2016.07.012
endence  in  ADL,  respectively.26 The  Lawton  I-ADL  scale
s  easy  to  perform  and  provides  self-reported  knowledge
bout  the  functional  skills  needed  to  live  in  the  commu-
ity,  such  as  the  ability  to  use  the  telephone  and  to  handle
ARTICLE IN PRESS+ModelBJANE-807; No. of Pages 8
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Table  1  Pre-admission  patient  characteristics  and  outcomes  (n  =  41).
Variable  --  n  (%)  or  median  (IQR)  All
n  =  41
No  PCD
n  =  31  (76)
PCD
n  =  10  (24)
p
Age  (years)  64  (57--70)  63  (56--69)  67  (60--73)  0.354a
Age  group  (years)  0.171b
<65  24  (59)  20  (64)  4  (40)
>65 17  (41)  11  (36)  6  (60)
Gender 0.610b
Male  13  (32)  10  (32)  3  (30)
Female 28  (68)  21  (68)  7  (70)
ASA-PS 0.642b
I/II  33  (80) 25  (81) 8  (80)
III/IV 8  (20)  6  (19)  2  (20)
Body mass  index  (kg/m2)  27  (25--30)  27  (25--30)  27  (26--31)  0.554a
Duration  of  anesthesia  (min)  120  (90--166)  120  (75--166)  124  (108--169)  0.594a
Type  of  anesthesia  0.181a
General/combined  32  (78)  24  (77)  8  (80)
Locoregional  9  (22) 7  (23)  2  (20)
Site of  surgery  0.453
Abdominal 24  (59)  18  (58)  6  (60)
Musculoskeletal  13  (32)  9  (29)  4  (40)
Head and  neck  4  (10)  4  (13)  0
Temperature  PACU  admission  (◦C)  35.6  (35.0--36.1)  35.8  (35.2--36.1)  35.0  (34.6--35.8)  0.170a
Hypertension  28  (68)  23  (74)  5  (50)  0.150b
Hyperlipidemia  22  (54)  16  (52)  6  (60)  0.463b
COPD  4  (10)  3  (10)  1  (10)  0.689b
STOP-Bang  ≥3  29  (71)  23  (74)  6  (60)  0.316
High-risk surgery  13  (32)  9  (29)  4  (40)  0.390b
Ischemic  heart  disease  4  (10)  4  (13)  0  0.390b
Congestive  heart  disease  1  (2)  1  (3)  0  0.756b
Cerebrovascular  disease  1  (2)  0  1  (10)  0.244b
Renal  insufﬁciency 2  (5)  1  3)  1  (10)  0.433b
Insulin  therapy  for  diabetes 5  (12) 4  (13)  1  (10)  0.647b
Benzodiazepines  11  (27)  8  (26)  3  (30)  0.546
Benzodiazepines  premedication 12  (29) 9  (29)  3  (30)  0.302
PACU length  of  stay  (min) 110  (90--138) 110  (90--140) 110  (58--129)  0.670a
PCD, postoperative cognitive decline; IQR, interquartile range; ASA-PS, American Society of Anesthesiologists physical status; COPD,
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b Pearson 2.
nances,  shopping, housekeeping,  food  preparation,  public
ransportation  and  responsibility  for  own  medications.25 The
atz  ADL  scale  evaluates  basic  personal  ADL  and  ranks  capa-
ility  of  performance  in  6  areas:  bathing,  dressing,  going  to
he  toilet,  transferring  from  bed  to  chair,  continence  and
eeding.25 The  patients’  answers  were  categorized  into  two
lasses:  capable  or  incapable  to  perform  each  activity  or
roup  of  activities.  They  were  considered  to  be  dependent  if
hey  were  incompetent  to  perform  at  least  one  instrumental
r  personal  ADL.
tatistical  analysisPlease  cite  this  article  in  press  as:  Borges  J,  et  al.  Impact  of  post
study.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.
escriptive  analysis  of  variables  was  used  to  summarize
ata.  Ordinal  and  continuous  data  found  not  to  follow  a
ormal  distribution,  based  on  the  Kolmogorov--Smirnov  test
or  normality  of  the  underlying  population,  are  presented
R
F
dit.
s  median  and  interquartile  range  (IQR).  Normally  dis-
ributed  data  are  presented  as  mean  and  standard  deviation
SD).  Non-parametric  tests  were  performed  for  comparisons
Wilcox  signed  rank  test  and  the  Mann--Whitney  U  test).  The
hi-square  test  or  Fisher’s  exact  test  were  used  to  compare
roportions  between  two  groups  of  subjects.  The  related
amples  Wilcoxon  signed  rank  test  was  used  to  compare  SF-
6  scores  before  surgery  and  three-months  after  surgery.
ifferences  were  considered  statistically  signiﬁcant  when  p
as  <0.05.  SPSS  software  for  Windows  Version  20.0  (SPSS
nc.,  Chicago,  IL,  USA)  was  used  for  all  statistical  analyzes.operative  cognitive  decline  in  quality  of  life:  a  prospective
bjane.2016.07.012
esults
rom  the  221  patients  consecutively  admitted  in  the  PACU
uring  the  study  period,  a  total  of  41  patients  were  included.
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Table  2  SF-36  in  patients  with  PCD.
T0  (median)  T3  (median)  p
Physical  function  83  75  0.779
Role physical  59  56  0.635
Bodily pain 43  67  0.314
General  health 53  49  0.674
Vitality  40  44  0.905
Social functioning  75  69  0.918
Role emotional  79  75  0.921
Mental  health  52  58  0.818
SF-36, 36-Item Short Form Health Survey; PCD, postoperative
cognitive decline; T0, before surgery; T3, 3 months after surgery.
Table  3  SF-36  in  patients  with  no  PCD.
T0  (median)  T3  (median)  p
Physical  function  70  65  0.289
Role physical  50  63  0.021a
Bodily  pain  62  74  0.022a
General  health  57  65  0.016a
Vitality  46  50  0.208
Social functioning  75  100  <0.001a
Role  emotional  67  92  0.014a
Mental  health  52  68  <0.001a
SF-36, 36-Item Short Form Health Survey; PCD, postoperative
Table  4  Comparing  groups  with  and  without  PCD  before
surgery  for  SF-36  (T0).
SF-36  domains  Without  PCD  With  PCD  p
Physical  function  70  83  0.772
Role physical  50  59  0.561
Bodily pain  62  43  0.407
General  health  57  53  0.465
Vitality  46  40  0.562
Social 75  75  0.736
Role emotional  67  79  0.288
Mental health 52  52  0.513
SF-36, 36-Item Short Form Health Survey; PCD, postoperative
cognitive decline; T0, before surgery.
Table  5  Comparing  groups  with  and  without  PCD  for  SF-36
3 months  after  surgery  (T3).
No  PCD
(median)
PCD
(median)
p
Physical  function  65  75  0.749
Role physical  63  56  0.192
Bodily pain  74  67  0.267
General  health  65  49  0.149
Vitality  50  44  0.269
Social functioning  100  69  0.200
Role emotional  92  75  0.153
Mental health  68  58  0.264
SF-36, 36-Item Short Form Health Survey; PCD, postoperative
cognitive decline; T3, 3 months after surgery.
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dcognitive decline; T0, before surgery; T3, 3 months after surgery.
a Statistically signiﬁcant, p < 0.05.
One-hundred  sixty-three  patients  were  excluded,  according
to  the  exclusion  criteria:  21  could  not  perform  preoperative
assessment,  112  had  less  than  45  years  old,  12  patients  were
admitted  to  a  surgical  intensive  care  unit,  8  patients  were
unable  to  provide  informed  consent  or  had  an  MMSE  < 24,  2
patients  did  not  undergo  surgery,  2  patients  underwent  neu-
rosurgery,  3  patients  did  not  speak  Portuguese  and  3  patient
refused  to  participate.  From  the  remaining  57  patients,  only
41  patients  have  completed  all  evaluations  for  cognitive
assessment  and  quality  of  life  at  three  months  follow-up.
The  characteristics  of  the  population  are  summarized
in  Table  1.  The  median  age  was  64  years  old.  78%  of  the
patients  underwent  general  or  combined  anesthesia  (gen-
eral  plus  locoregional  anesthesia,  and  the  median  time  for
its  duration  was  120  min.  Gastrointestinal  surgery  accounted
for)  49%  of  the  cases,  plastic  and  reconstructive  surgery  to
15%,  gynecologic  surgery  and  orthopedics,  each  10%,  urol-
ogy  to  8%,  vascular  to  4%,  head  and  neck  surgery  to  3%  and
otorhinolaryngology  to  1%  of  the  cases.  No  statistically  sig-
niﬁcant  differences  between  patients  with  and  without  PCD
were  recorded  for  the  studied  variables.
The  incidence  of  PCD,  3  months  after  surgery,  was  24%
(n  =  10).  At  T0,  no  differences  emerged  for  the  MOCA  scores
between  patients  with  and  without  cognitive  impairment
(median  25  vs.  21,  p  =  0.139).  At  T3,  however,  patients  with
PCD  had  worse  median  MOCA  scores  (20  vs.  25,  p  =  0.009).
Comparing  to  preoperative  MOCA  scores,  PCD  patients  had
worse  MOCA  median  scores  at  T3  (20  vs.  25,  p  =  0.001),  whilePlease  cite  this  article  in  press  as:  Borges  J,  et  al.  Impact  of  post
study.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.
patients  without  PCD  had  better  scores  (25  vs.  21,  p  <  0.001).
Tables  2  and  3  present  median  scores  of  SF-36  domains
for  both  groups  of  patients,  comparing  T0  and  T3  score.  For
f
p
2atients  with  PCD,  and  comparing  each  of  SF-36  domains  at
0  and  T3,  there  are  similar  scores  for  every  of  the  eight
F-36  domains  (Table  2). Patients  without  PCD  had  better
cores  at  T3  in  six  domains  (Table  3):  role  limitations  caused
y  physical  problems  (median  63  vs.  50,  p  =  0.021),  bodily
ain  (median  74  vs.  62,  p  =  0.022),  general  health  percep-
ion  (median  65  vs.  57,  p  =  0.016),  social  functioning  (median
00  vs.  75,  p  <  0.001),  role  limitations  caused  by  emotional
roblems  (median  92  vs.  67,  p  =  0.014)  and  mental  health
median  68  vs.  52,  p  <  0.001)  and  they  had  similar  scores  for
itality  (p  =  0.208)  and  physical  function  (p  =  0.289)  domains.
Tables  4  and  5  present  the  median  scores  for  all  SF-36
omains  obtained  before  and  after  surgery,  respectively,
omparing  patients  with  and  without  PCD.  As  exhibited,  at
0  and  T3  all  scores  for  SF-36  domains  were  similar.
In  Table  6  it  is  shown  that  at  T0  there  were  similar  rates
f  dependency  in  P-ADL  and  I-ADL,  when  comparing  patients
ith  and  without  PCD;  however,  at  T3  patients  with  PCD
resented  with  higher  levels  of  dependency  in  P-ADL  (50%
s.  16%,  p  =  0.030).  Comparing  their  rates  of  dependency
t  T0  with  T3  and  for  patients  with  PCD  there  is  a  higher
ependence  scores  in  I-ADL  (50%  vs.  10%,  p  =  0.037)  but  not
or  P-ADL  (10%  vs.  10%,  p  =  1.0).  In  the  same  comparison,
atients  without  PCD  had  no  differences  in  I-ADL  (29%  vs.
9%,  p  =  1.0)  or  P-ADL  dependency  (3%  vs.  7%,  p  =  0.572).operative  cognitive  decline  in  quality  of  life:  a  prospective
bjane.2016.07.012
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Table  6  Independency  in  activities  of  daily  living  before
and after  surgery.
ADL  No  PCD
(n  =  31)
PCD
(n  =  10)
p
I-ADL  at  T0,  n  (%) 2  (7) 1  (10) 0.578
P-ADL at  T0,  n  (%) 7  (23) 1  (10) 0.358
I-ADL at  T3,  n  (%)  1  (3)  1  (10)  0.433
P-ADL at  T3,  n  (%)  5  (16)  5  (50)  0.030*
ADL, instrumental activities of daily living; P-ADL, personal
activities of daily living; T0, before surgery; T3, 3 months after
surgery.
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All  authors  conﬁrm  that  they  have  read  and  approved  theiscussion
e  report  an  incidence  of  PCD  of  24%,  three  months  follow-
ng  surgery.  In  literature,  the  incidence  of  PCD  is  not  clearly
eﬁned  and  may  vary  between  25%  and  80%.4,13 Many  current
eports  establish  that  surgery,  particularly  cardiac  surgery,
ay  result  in  PCD  and  that  its  incidence  increases  with  age,
ndependently  of  the  anesthetic  technique.11
PCD  can  have  a  considerable  impact  on  quality  of  life
nd  may  result  in  withdrawal  from  society.11,13,15,17 In  recent
ears,  PCD  after  non-cardiac  surgery  has  been  systemati-
ally  studied.  In  particular  the  ISPOCD  (International  Study
roup  of  Postoperative  Cognitive  Dysfunction)  was  success-
ul  in  uncovering  the  extent  of  the  problem  and  deﬁning  risk
actors.  Early  PCD  occurs  in  approximately  25%  of  patients
ne  week  after  surgery,  and  then  declines  to  less  than  10%
fter  three  months.6
PCD  refers  to  deterioration  in  cognition  temporally
ssociated  with  operation;  thus,  the  growing  number  of
lderly  patients  undergoing  surgery  should  aware  anes-
hesiologists  and  surgeons  to  its  serious  repercussions.11
evertheless,  there  is  no  explicit  information  if  any  change
n  procedures  would  change  the  incidence  of  PCD,  but  it
s  possible  that  preoperative  medication,  anticholinergic,
atecholamine’s,  and  some  events  such  as  hypotension,
ypothermia,  hypoxia,  cerebral  atheroembolism  or  hypoper-
usion,  poor  glycemic  control  and  carotid  endarterectomy
ay  contribute  to  high  incidence  levels  of  PCD.2 In  our  study,
e  did  not  found  differences  related  to  patient  demographic
ariables  or  anesthesia  or  surgical  characteristics.
In  the  multiple  PCD  studies  there  has  not  been  a  standard
ethodology  used33 and  the  choice  of  neuropsychological
est  instruments,  the  criteria  to  consider,  the  timing  of  test-
ng  and  retesting,  and  inclusion  and  exclusion  criteria  have
ll  varied.34
The  use  of  highly  sensible  and  speciﬁc  neuropsycholo-
ical  tests  allows  for  the  identiﬁcation  of  subtle  cognitive
eﬁcits  with  excellent  test/retest  validity,  but  with  highest
isk  of  type  II  errors  (failing  to  detect  PCD).  For  this  study,
he  MOCA  test  was  chosen  because  it  is  easy  and  quick  to
erform  and  enables  the  evaluation  of  several  functional
omains  of  cognition.  Even  so,  it  may  fail  to  identify  some
atients  with  milder  forms  of  PCD.35,36Please  cite  this  article  in  press  as:  Borges  J,  et  al.  Impact  of  post
study.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.
Perioperative  interventions  have  long-range  effects  on
he  individual,  so  strategies  to  preserve  long-term  cognitive
erformance  and  quality  of  life  are  required.37
p
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The  risk  of  cognitive  decline  increases  with  age  and  is
urther  enhanced  after  hospitalization  for  surgery,  result-
ng  in  signiﬁcant  morbidity  and  reduced  quality  of  life.38
ctually,  there  is  no  individual  approach  to  avoid  cognitive
eterioration2 but  the  maintenance  and/or  restoration  of
unctional  independence,  including  cognition,  in  the  elderly
ospitalized  patient  constitutes  a  major  challenge  for  the
ealth  care  system.
The  postoperative  cognitive  decline  may  diminish
mprovements  in  QOL  and  strategies  to  reduce  cogni-
ive  decline  may  allow  patients  to  achieve  the  maximum
mprovement  in  QOL  after  surgery.  This  has  been  the  sub-
ect  of  various  studies7 and  like  them  the  present  study
emonstrated  that  cognitive  decline  limited  improvement
n  QOL.
Even  mild  cognitive  deﬁcits  before  surgery  may  be  a
arker  for  increased  risk  of  cognitive  decline39 and  also  it
as  been  accepted  that  PCD  generally  resolve  within  1--3
onths  in  most  patients  in  whom  new  cognitive  symptoms
evelop  during  postoperative  period.33,39,40
Three  months  after  surgery  a signiﬁcant  improvement  in
uality  of  life  in  patients  without  PCD  was  demonstrated
y  an  increase  in  almost  all  scores  of  SF-36  domains,  but
mongst  patients  with  PCD,  no  improvement  was  seen  in  any
f  the  SF-36  scores.  This  limitation  in  quality  improvement
s  also  demonstrated  in  PCD  patients  by  a  signiﬁcant  more
ependency  in  P-ADL  three  months  after  surgery  comparing
ith  patients  without  PCD.
This  study  has  several  limitations.  It  is  an  observational
tudy,  with  a  small  sample  of  patients.  It  has  many  dropouts
nd  losses  to  the  follow-up  (explained,  in  part,  by  the  need
o  have  complete  interviews  before  and  after  the  surgery,
or  follow-up  consultation).  Furthermore,  we  did  not  stud-
ed  clinical  variables  after  surgery,  including  complications
nd  medications  that  may  have  affected  not  only  the  losses
o  follow-up  but  also  the  results  in  cognitive  performance,
uality  of  life  and  independence  in  ADL.
onclusions
he  principal  ﬁndings  of  this  study  were  as  follow:  (1)  the
ncidence  of  PCD  was  of  24%;  (2)  patients  with  PCD  shown
o  improvements  in  quality  of  life  scores;  and  (3)  patients
ithout  PCD  shown  better  scores  in  almost  all  SF-36  domains
nd  an  increase  in  dependency,  after  surgery.
PCD  is  a  real  event,  with  real  complications  and  con-
equences  in  the  quality  of  life,  which  requires  a  better
nderstanding,  especially  in  terms  of  etiologic  factors  in
rder  to  prevent  them.  It  should  not  be  overestimated  as
t  decreases  the  quality  of  life  and  enhances  the  degree  of
ependence  for  activities  of  daily  living,  and  high-quality
erioperative  care  and  support  are  social  and  ﬁnancial  are
ssential.
uthorshipoperative  cognitive  decline  in  quality  of  life:  a  prospective
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